GC2302 Study Site 104 — Asheville, North Carolina

GC2302 Study Site 104 is a clinical research site located in Asheville, North Carolina, United States 28803.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

GC2302 Study Site 104 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Dry Eye Disease.

Sponsors: Instituto Grifols, S.A..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2302 Study Site 104?

GC2302 Study Site 104 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2302 Study Site 104 conducted?

GC2302 Study Site 104 has 1 clinical trials on record, with 1 currently active. Their work covers Dry Eye Disease.

Is GC2302 Study Site 104 accredited by Crixeo Health?

GC2302 Study Site 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2302 Study Site 104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.